These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 27435923)

  • 1. A Multiplexed Cytokeratin Analysis Using Targeted Mass Spectrometry Reveals Specific Profiles in Cancer-Related Pleural Effusions.
    Domanski D; Perzanowska A; Kistowski M; Wojtas G; Michalak A; Krasowski G; Dadlez M
    Neoplasia; 2016 Jul; 18(7):399-412. PubMed ID: 27435923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An MRM-Based Cytokeratin Marker Assay as a Tool for Cancer Studies: Application to Lung Cancer Pleural Effusions.
    Perzanowska A; Fatalska A; Wojtas G; Lewandowicz A; Michalak A; Krasowski G; Borchers CH; Dadlez M; Domanski D
    Proteomics Clin Appl; 2018 Mar; 12(2):. PubMed ID: 29352525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosing pleural effusions using mass spectrometry-based multiplexed targeted proteomics quantitating mid- to high-abundance markers of cancer, infection/inflammation and tuberculosis.
    Robak A; Kistowski M; Wojtas G; Perzanowska A; Targowski T; Michalak A; Krasowski G; Dadlez M; Domański D
    Sci Rep; 2022 Feb; 12(1):3054. PubMed ID: 35197508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of a panel of tumor markers (carcinoembryonic antigen, cancer antigen 125, carbohydrate antigen 15-3, and cytokeratin 19 fragments) in pleural fluid for the differential diagnosis of benign and malignant effusions.
    Porcel JM; Vives M; Esquerda A; Salud A; Pérez B; Rodríguez-Panadero F
    Chest; 2004 Dec; 126(6):1757-63. PubMed ID: 15596670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In-depth proteomic analysis of six types of exudative pleural effusions for nonsmall cell lung cancer biomarker discovery.
    Liu PJ; Chen CD; Wang CL; Wu YC; Hsu CW; Lee CW; Huang LH; Yu JS; Chang YS; Wu CC; Yu CJ
    Mol Cell Proteomics; 2015 Apr; 14(4):917-32. PubMed ID: 25638566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of cytokeratin MNF116 and vimentin in pleural serous effusions.
    Mocanu L; Cîmpean AM; Raica M
    Rom J Morphol Embryol; 2007; 48(3):291-4. PubMed ID: 17914498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical value of CYFRA21-1, NSE, CA15-3, CA19-9 and CA125 assay in the elderly patients with pleural effusions.
    Li CS; Cheng BC; Ge W; Gao JF
    Int J Clin Pract; 2007 Mar; 61(3):444-8. PubMed ID: 17313612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different expression of FoxM1 in human benign and malignant pleural effusion.
    Tang Z; Li H; Zhu H; Bai C
    Med Oncol; 2015 Jan; 32(1):312. PubMed ID: 25491139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular endothelial growth factor in pleural fluid for differential diagnosis of benign and malignant origin and its clinical applications.
    Fiorelli A; Vicidomini G; Di Domenico M; Napolitano F; Messina G; Morgillo F; Ciardiello F; Santini M
    Interact Cardiovasc Thorac Surg; 2011 Mar; 12(3):420-4. PubMed ID: 21172937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic value of soluble receptor-binding cancer antigen expressed on SiSo cells and carcinoembryonic antigen in differentiating malignant from benign pleural effusion.
    Dong J; Sun G; Zhu H
    Tumour Biol; 2016 Mar; 37(3):3257-64. PubMed ID: 26438059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigation of volatile organic metabolites in lung cancer pleural effusions by solid-phase microextraction and gas chromatography/mass spectrometry.
    Liu H; Wang H; Li C; Wang L; Pan Z; Wang L
    J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Jan; 945-946():53-9. PubMed ID: 24321761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor markers in pleural effusions.
    Topolcan O; Holubec L; Polivkova V; Svobodova S; Pesek M; Treska V; Safranek J; Hajek T; Bartunek L; Rousarova M; Finek J
    Anticancer Res; 2007; 27(4A):1921-4. PubMed ID: 17649796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of CYFRA 21-1 in malignant and benign pleural effusions.
    Toumbis M; Rasidakis A; Passalidou E; Kalomenidis J; Alchanatis M; Orphanidou D; Jordanoglou J
    Anticancer Res; 1996; 16(4A):2101-4. PubMed ID: 8712750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted proteomics pipeline reveals potential biomarkers for the diagnosis of metastatic lung cancer in pleural effusion.
    Chen CD; Wang CL; Yu CJ; Chien KY; Chen YT; Chen MC; Chang YS; Wu CC; Yu JS
    J Proteome Res; 2014 Jun; 13(6):2818-29. PubMed ID: 24787432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiopoietin-2 levels are elevated in exudative pleural effusions.
    Kalomenidis I; Kollintza A; Sigala I; Papapetropoulos A; Papiris S; Light RW; Roussos C
    Chest; 2006 May; 129(5):1259-66. PubMed ID: 16685017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic value of tumor markers in lung adenocarcinoma-associated cytologically negative pleural effusions.
    Hsieh TC; Huang WW; Lai CL; Tsao SM; Su CC
    Cancer Cytopathol; 2013 Sep; 121(9):483-8. PubMed ID: 23408492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic utility of serum and pleural fluid carcinoembryonic antigen, neuron-specific enolase, and cytokeratin 19 fragments in patients with effusions from primary lung cancer.
    Lee JH; Chang JH
    Chest; 2005 Oct; 128(4):2298-303. PubMed ID: 16236887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The reactivity to CK5/6 antibody in tumor cells from non-small cell lung cancers shed into pleural effusions predicts survival.
    Dejmek JS; Dejmek A
    Oncol Rep; 2006 Mar; 15(3):583-7. PubMed ID: 16465416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of serum and pleural levels of soluble B7-H4 in lung cancer patients with pleural effusion.
    Xu C; Qian L; Yu L; Zhang X; Wang Q
    Biomarkers; 2015; 20(4):271-4. PubMed ID: 26301886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic value of MUC1 and EpCAM mRNA as tumor markers in differentiating benign from malignant pleural effusion.
    Sun W; Li J; Jiang HG; Ge LP; Wang Y
    QJM; 2014 Dec; 107(12):1001-7. PubMed ID: 24939190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.